Navigation Links
New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease
Date:10/31/2011

re taking concomitant immunosuppressants such as methotrexate or corticosteroids.  CIMZIA should be discontinued if a patient develops a serious infection or sepsis.  Reported infections include:

  • Active tuberculosis, including reactivation of latent tuberculosis.  Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease.  Patients should be tested for latent tuberculosis before CIMZIA use and during therapy.  Treatment for latent infection should be initiated prior to CIMZIA use.  
  • Invasive fungal infections, including histoplasmosis , coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis.  Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized disease.  Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection.  Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness .
  • Bacterial, viral and other infections due to opportunistic pathogens, including Legionella and Listeria.

The risks and benefits of treatment with CIMZIA should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.  Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with CIMZIA, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which CIMZIA is a member.  CIMZIA is not indicated for use in pediatric patients.

Patients treated with CI
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
2. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
3. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
4. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
5. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
6. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
7. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
8. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
9. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
10. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
11. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- QT Vascular Ltd., together with its subsidiaries (the ... subsidiaries, the "Group"), a global company engaged in ... solutions for the minimally invasive treatment of vascular ... below-the-knee ("BTK") cohort of patients in the Chocolate® ... August 15, 2015 at the 5th Annual Amputation ...
(Date:8/31/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wmn42n/prescription_pain ... "Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ ... Competitors and Opportunities: 2015 - 2020 Analysis and ... Pain is defined as an unpleasant sensory ... tissue damage. At some point, everyone experiences pain. ...
(Date:8/29/2015)... August 29, 2015 La ... para los sistemas de imagen por Ultrasonidos   ofrece ... de examen rápidos y un flujo de trabajo   ... en el proceso de detección de Cardiopatías   ... anunciado hoy el lanzamiento europeo de HeartModel A.I ...
Breaking Medicine Technology:Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5
(Date:8/31/2015)... ... August 31, 2015 , ... Chicago-based company The ... Pink® to raise money and awareness for breast and ovarian health. During ... Sassy incandescent Mood-lite sold to Bright Pink® to encourage households, dorms, and offices ...
(Date:8/31/2015)... NC (PRWEB) , ... August 31, 2015 , ... ... solutions firm, introduces the Talent Management Division , a department devoted to ... the sales department. Talent management goes beyond selection, and The Brooks Group believes ...
(Date:8/31/2015)... ... 31, 2015 , ... ERT, a leading global provider of ... will demonstrate multiple prototypes from its Innovation Lab during its 8th Annual European ... only European event dedicated to providing case studies and pragmatic information on the ...
(Date:8/31/2015)... ... August 31, 2015 , ... NSF ... for the water, food, health sciences and consumer goods industries, has recognized Clean ... advanced iron filtration media, Pro-OX Manganese Dioxide. , Developed by a team of ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... GenHart Software, ... it their business to help small businesses operate as efficiently and cost effectively as ... already made an impact in their first year of operation – and the Charleston ...
Breaking Medicine News(10 mins):Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 3Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3
... ... that provide customized allergy information to its users. MyPollen automatically provides users with allergy ... track of their allergy symptoms. , ... (Vocus) February 18, 2010 -- Pollen.com , the most visited ...
... ... of Sales , ... Cambridge, MD (PRWEB) February 18, 2010 -- RPS ISG International recently announced the appointment ... technology program . Cummings oversees new business production in ISG’s technology program. , ...
... More could be transplanted if doctors would put them on ... -- Too many American seniors who need a new kidney ... say. , In a new study, Johns Hopkins researchers analyzed ... patients over age 65 experience unnecessary delays because their doctors ...
... spur rare thyroid tumor, but experts say effects in ... -- The U.S. Food and Drug Administration is defending ... diabetes drug, Victoza (liraglutide), even though animal studies suggest ... cancer. , Victoza, among a class of medicines called ...
... ... Takes “Going Green” to the Next Level., , ... Tampa, FL (PRWEB) February 18, 2010 -- Super ... and eco-friendly tankless water heaters on the market today. Super Green Technologies water ...
... DC (February 18, 2010) Can patients near death ... and their families, wishes? This practice, which is on ... by palliative care researchers and practitioners. Now palliative care ... their experiences and data, and developed a standard checklist ...
Cached Medicine News:Health News:Pollen.com Launches Features to Customize Allergy Information - ,Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms 2Health News:Pollen.com Launches Features to Customize Allergy Information - ,Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms 3Health News:Pollen.com Launches Features to Customize Allergy Information - ,Top Allergy Web Site Provides ZIP-specific Allergy Information and Diary to Track Symptoms 4Health News:CCBsure Names New Area Vice-President of Sales 2Health News:Kidneys From Older Donors Suitable for Seniors 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 3Health News:First Breakthrough in Water Heating Technology! 2Health News:First Breakthrough in Water Heating Technology! 3Health News:Home palliative sedation checklist may ease concerns 2Health News:Home palliative sedation checklist may ease concerns 3
... automatic systems for performing erythrocyte sedimentation rate ... With the introduction of the Ves-matic System ... a truly revolutionary testing system which addresses ... the traditional ESR techique.,By means of a ...
... A complete range of automatic systems ... using 1 mL of blood. With the ... to the clinical diagnostic market a truly ... every technical limitation associated with the traditional ...
... VACUETTE erythrocyte sedimentation rate analysers, which ... new generation unites the well-established advantages ... range of additional innovations which guarantee ... sedimentation rate. Cost effectiveness is an ...
... analyzer that brings about the ... Up to 40 test per ... bach, with automated mixing. It ... back-up support or to be ...
Medicine Products: